Microbial Air Monitoring Facilitates Disease Surveillance and Outbreak Response

SARS-CoV-2 spreads through airborne transmission. Aerosols containing live virus are dispersed when an infected person exhales and can accumulate indoors, putting others at risk.

Microbial air monitoring is one of the essential pillars of disease surveillance and management. Routine air sampling in crowded indoor spaces such as airports, hospitals, schools, malls and offices serves as an early warning mechanism, not just for SARS-CoV-2, but also other airborne pathogens. Microbial air monitoring provides useful information about viral prevalence in a population. Air monitoring can also be used as an alternative screening tool when mass diagnostic testing is not feasible. Early identification of pathogens and variants of concern allows for timely implementation of mitigation strategies and informs vaccine development.

Join this webinar to learn about the solutions for effective air monitoring. The featured speaker will also discuss how public health systems around the world have implemented these approaches to monitor COVID-19, as well as other human and animal disease outbreaks.

Supplementary Materials:

Environmental Testing (sartorius.com)

Air Monitoring | Pharmaceutical Microbiology | Sartorius

Keywords:

Speaker

Eric Clement Arakel, Global Project Manager, Sartorius

Eric Arakel is the global product manager of the Microbial Air Monitoring and Sterility Testing portfolios at Sartorius. He is a protein biochemist and molecular biologist by training and has been with Sartorius in this role for two years now.

Message Presenter

Who Should Attend?

Vaccine R&D Labs and Vaccine Developers
Scientists
Lab Managers and Lab Technicians
Air/Environmental testing laboratories
Disease Control Institutes

What You Will Learn

The importance of air monitoring for airborne pathogens
The solutions for accurate air monitoring
Case studies showing effective implementation

Xtalks Partner

Sartorius

Partner of Life Science Research and the Biopharmaceutical Industry

Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Hundreds of millions of people lack access to affordable and safe medicines. Our biopharma customers are working hard to develop new drugs to improve people’s lives. For that they need strong partners to be successful.

The Sartorius Group is a leading international partner of the biopharmaceutical industry and the research sector. We are helping biotech scientists and engineers across the entire globe to develop and manufacture medications from the first idea to production. So more people will have access to better medicine.